FIELD: medicine.
SUBSTANCE: invention relates to field of pharmaceutics and concerns medication for peroral application for treatment of dopaminergic system disorders, which includes aplindore and one or some slowing down release polymers.
EFFECT: medicine provides reduction of side effects caused by aplindore introduction.
42 cl, 13 tbl, 10 ex
Authors
Dates
2009-12-27—Published
2004-10-28—Filed